Abstract:A nanoparticle (Combo‐NP) that contains biodegradable NIR‐II‐fluorescent pseudo conjugate polymer with disulfide bonds in the main chain (TPA‐BD) and a vascular inhibitor Lenvatinib (Len) is designed. Combo‐NP not only kill tumors by generating reactive oxygen species (ROS), but also trigger immunogenic cell death (ICD) initiating cascade immune responses leading to the production of cytotoxic T lymphocytes (CTLs). Moreover, Combo‐NP alleviate hypoxia by normalizing the tumor vessels, thereby improving the Photodynamic therapy (PDT)efficiency and increasing the infiltration of CTLs. These effects combine to amplify the photodynamic‐immunotherapy of the nanoparticles exhibiting promising inhibitory effects on tumor metastasis and inducing an abscopal immune response when combine with anti‐programmed death‐ligand 1 (PD‐L1) immunotherapy. Photodynamic therapy (PDT) has been widely employed in tumor treatment due to its effectiveness. However, the tumor hypoxic microenvironment which is caused by abnormal vasculature severely limits the efficacy of PDT. Furthermore, the abnormal vasculature has been implicated in the failure of immunotherapy. In this study, a novel nanoparticle denoted as Combo‐NP is introduced, composed of a biodegradable NIR II fluorescent pseudo‐conjugate polymer featuring disulfide bonds within its main chain, designated as TPA‐BD, and the vascular inhibitor Lenvatinib. Combo‐NP exhibits dual functionality by not only inducing cytotoxic reactive oxygen species (ROS) to directly eliminate tumor cells but also eliciting immunogenic cell death (ICD). This ICD response, in turn, initiates a robust cascade of immune reactions, thereby augmenting the generation of cytotoxic T lymphocytes (CTLs). In addition, Combo‐NP addresses the issue of tumor hypoxia by normalizing the tumor vasculature. This normalization process enhances the efficacy of PDT while concurrently fostering increased CTLs infiltration within the tumor microenvironment. These synergistic effects synergize to potentiate the photodynamic‐immunotherapeutic properties of the nanoparticles. Furthermore, when combined with anti‐programmed death‐ligand 1 (PD‐L1), they showcase notable inhibitory effects on tumor metastasis. The findings in this study introduce an innovative nanomedicine strategy aimed at triggering systemic anti‐tumor immune responses for the treatment of Uveal melanoma.

Reshaping Tumor Blood Vessels to Enhance Drug Penetration with a Multistrategy Synergistic Nanosystem

Modulating Tumour Vascular Normalisation Using Triptolide-Loaded NGR-functionalized Liposomes for Enhanced Cancer Radiotherapy

"Targeted Plus Controlled" - Composite Nano Delivery System Opens the Tumor Vascular and Microenvironment Normalization Window for Anti-Tumor Therapy.

Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment

Remodeling the tumor microenvironment by vascular normalization and GSH-depletion for augmenting tumor immunotherapy

Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect.

Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization promoting nanomedicines.

Nano Drug Delivery System Reconstruct Tumour Vasculature for the Tumour Vascular Normalisation

Anti-angiogenic Nano-Delivery System Promotes Tumor Vascular Normalizing and Micro-Environment Reprogramming in Solid Tumor

Jet-Lagged Nanoparticles Enhanced Immunotherapy Efficiency through Synergistic Reconstruction of Tumor Microenvironment and Normalized Tumor Vasculature

Normalizing Tumor Vessels to Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment

Tumor Vasculature Normalization by Orally Fed Erlotinib to Modulate the Tumor Microenvironment for Enhanced Cancer Nanomedicine and Immunotherapy.

Correction to Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.

Nanodrugs Reprogram Cancer-Associated Fibroblasts and Normalize Tumor Vasculatures for Sequentially Enhancing Photodynamic Therapy of Hepatocellular Carcinoma

Combination of Tumor Vessel Normalization and Immune Checkpoint Blockade for Breast Cancer Treatment Via Multifunctional Nanocomplexes.

Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.

Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis

Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles.

Biomimetic Nanomodulators With Synergism of Photothermal Therapy and Vessel Normalization for Boosting Potent Anticancer Immunity

Enhanced Nanodrug Delivery to Solid Tumors Based on a Tumor Vasculature-Targeted Strategy

Tumor Priming Using Metronomic Chemotherapy with Neovasculature-Targeted, Nanoparticulate Paclitaxel